Harry Schrickx, VP, Business Development and Marketing

Mr. Schrickx joined OncoMethylome Sciences on May 2003 with 22 years of experience in the biotech industry at Organon Teknika (AKZONOBEL) and, after a take-over in July 2001, bioMĂ©rieux where he held several senior management positions. Amongst others he was the head of Global Marketing in 1990-1991, General Manager of Organon Teknika France (1991-1992), Sr […]

Herman Spolders , Chief Executive Office

Mr. Spolders has 30 years of experience in the biotech industry in Europe and the U.S. Throughout his career, Mr. Spolders has been instrumental in forging large pharma-biotech collaborations, growing research and development organizations, defining new product opportunities, and protecting intellectual property. In addition to direct management experience, Mr. Spolders has served on the board […]

Joseph Bigley, M.Sc., VP Clinical Development

Mr. Bigley joined OncoMethylome Sciences at inception from Tibotec-Virco where he had been Director, Oncology Clinical Research since January 2001. Prior to Tibotec-Virco, Mr. Bigley was Director, Clinical Operations and Associate Clinical Director, Oncology at Triangle Pharmaceuticals from 1998 to 2000, where he led the development team of three products in HIV/AIDS and cancer. He […]

Philip Devine, MBA, CPA, Chief Financial Officer

Mr. Devine joined OncoMethylome Sciences at its inception. Prior to joining OncoMethylome Sciences, Mr. Devine served as chief financial officer of Tibotec-Virco, where he managed its sale to Johnson and Johnson. Previously, he was a manager at the management consulting firm McKinsey & Company and an auditor at Deloitte & Touche, where he conducted numerous […]

James DiGuiseppi, Ph.D., Chief Technology Officer

Dr. DiGuiseppi became a member of the OncoMethylome Sciences Management team, as Chief Technology Officer, in August 2005. Dr. DiGuiseppi has held several senior scientific and managerial posts with Organon Teknika Corp. and bioMerieux, including senior vice-president positions in research and development, global marketing and strategic development. He was most recently vice-president of process development […]

Katja Bierau, Ph.D., Director, Research and Development

Dr. Bierau, Director Research and Development since August 2003, earned a Ph.D. degree in Cancer Studies from Birmingham University (UK), and an MSc degree in Biotechnology (Bingen, Germany). Most recently she was Group Leader ADMET at PamGene International in The Netherlands developing gene-based high-throughput screening assays used for pre-clinical drug development. As it was mentioned […]

Wim Van Criekinge, Ph.D., Prof., VP Biomarker and Pharmacogenomics Research

Prof. Van Criekinge joined OncoMethylome Sciences in August 2005. He graduated in 1994 as a Chemical Engineer from the University of Ghent, Belgium, where he earned his PhD in Molecular Biology in 1998. Today he is part-time Professor at the same university where he is head of the laboratory for computational genomics and bioinformatics (Biobix) […]

Joost Louwagie, Ph.D., VP, Product Development

Dr. Louwagie joined the OncoMethylome Sciences Management Team in February 2005 as Vice President Product Development. He earned his PhD in Biochemistry from the University of Leuven (Belgium) followed by post-doctoral studies at the Institute of Tropical Medicine (Belgium) and the Walter Reed Army Hospital (U.S.). Before joining OncoMethylome Sciences, Dr. Louwagie worked at Innogenetics […]

Luc Segers, Senior Director Business Development

Mr. Segers joined OncoMethylome in 2006 after 15 years of experience at diagnostics company Innogenetics, where he held senior management positions in sales and marketing. Prior to Innogenetics, Mr. Segers spent five years in international marketing at Organon Teknika. Mr. Segers is responsible for business development in Europe, particularly for pharmacogenomics, licensing, and commercialization projects. […]

Joseph Sollee, J.D., LLM, Group General Counsel

Mr. Sollee has provided legal counsel to OncoMethylome Sciences since its inception in 2003, and in April 2008 joined our management team as Group General Counsel. Prior to joining OncoMethylome Sciences, Mr. Sollee served as Special Counsel with the law firm of Kennedy Covington, where he led the Life Sciences Practice Group. Mr. Sollee has […]